Project Grant R34CA283480
Award Date
9/13/24
Completion Date
8/31/27
Dollars Obligated
$332K
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), aims to characterize skin cancer-related communication on social media and develop effective prevention-focused messages for adolescents and young adults (AYAs) aged 15-20 years. The total funding amount is $542,724.00, awarded on September 3, 2024 with a project period through August 31, 2028. The project has three specific aims: 1) characterize...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $706,771 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to evaluate the impact of a precision prevention intervention on improving skin cancer prevention activities among diverse patients in low-resourced, community primary care settings. The 5-year study aims to (1) evaluate the effectiveness of the precision prevention intervention in improving...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to Dartmouth-Hitchcock Clinic is focused on understanding the role of melanocyte PD-L1 expression in modulating the immune response to UV-induced melanoma. The $635,946 award, with a performance period from July 2024 to June 2029, will support research using an autochthonous mouse melanoma model to investigate how UV radiation-induced interferon-I signaling and tumor inflammatory memory...
The federal Project Grant award, valued at $312,892.00 and provided by the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), supports research at Duke University to investigate the role of Type 3 innate lymphoid cells (ILC3s) in regulating the melanoma tumor microenvironment. The goal is to better understand how ILC3s modulate adaptive immune responses and create immunosuppressive conditions that may contribute to the failure of immune checkpoint inhibitor...
This federal Project Grant award of $231,710 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports research to develop artificial intelligence (AI)-based measures of microscale pedestrian environment features (PEFs) in rural areas. The goals are to: 1) validate existing machine learning algorithms to assess 9 microscale PEFs (e.g., sidewalks, crosswalks, lighting) for rural areas, 2) test the relationship between rural microscale...
This federal Project Grant award, valued at $705,263.00 and effective from September 30, 2024 to September 29, 2027, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research at Northwestern University's Sponsored Research Division to conduct single-cell tracking of the transformation of lung adenocarcinoma to small cell lung cancer. This cutting-edge research aims to advance the scientific understanding of lung...
This $958,434 federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research by The Leland Stanford Junior University to elucidate the molecular mechanisms of RET kinase regulation in human epidermis and define RET-regulated impacts on the tumor immune microenvironment. The long-term goal is to develop topical selective RET inhibitors for effective therapeutic prevention of cutaneous squamous cell carcinoma (CSCC). The proposed research...
This Project Grant award from the National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research) provides $349,878 to the University of Utah to develop and evaluate an Electrical Impedance Dermography (EID) technology for distinguishing different subtypes of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) from benign skin lesions. The key objectives are to: Use EID data and machine learning to create a diagnostic algorithm that can accurately differentiate BCC...
This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and evaluation of a mobile-optimized intervention called PERCS-YA (Personalized Cancer Support for Young Adults) to reduce worry and distress among young adult cancer survivors. The award will fund stakeholder-engaged refinement of the PERCS-YA intervention, followed by a Phase II efficacy trial utilizing both a...
The National Cancer Institute (NCI) awarded a Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) in the amount of $1,128,600 to the University of Utah on July 17, 2024. The purpose of this grant is to develop and evaluate a clinician-facing mobile health (mHealth) app, called Color Me Healthy, that integrates with electronic health record (EHR) systems to improve symptom communication and management for children with cancer during the early cancer treatment period. The project...